Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Stevanato Group (STVN) just posted its third quarter 2026 earnings, reporting sales of €326.1 million and net income of €41.8 million. These results give investors fresh numbers to reassess the stock. Despite the solid Q3 report and the Aptar Pharma collaboration announced in
Directly affected
- STVN Stevanato Group S.p.A
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| STVN | +37.79% | +36.05% | base | -4.97% | -6.60% | -3.97% | -3.19% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings Yahoo Finance Singapore
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| STVN | that day | -4.97% | final price |
| STVN | the next day | -6.60% | final price |
| STVN | two days later | -3.97% | final price |
| STVN | three days later | -3.19% | final price |
| STVN | three days earlier | +36.05% | final price |
| STVN | five days earlier | +37.79% | final price |
This story
12 out of 100
“Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings” scores 12 out of 100. The score uses 1 sources.